Form 8-K - Current report:
SEC Accession No. 0000914475-22-000050
Filing Date
2022-08-30
Accepted
2022-08-30 08:01:13
Documents
13
Period of Report
2022-08-30
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20220830.htm   iXBRL 8-K 30759
5 GRAPHIC nbix-20220830_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-22-000050.txt   215740

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20220830.xsd EX-101.SCH 1908
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20220830_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20220830_pre.xml EX-101.PRE 12512
7 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20220830_htm.xml XML 10844
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 221212917
SIC: 2836 Biological Products, (No Diagnostic Substances)